Quick Order Cart

Cat. No. ARG1122

CNTROB Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

CRISPR/Cas9-edited polyclonal Raji B lymphocyte population with targeted disruption of the CNTROB gene, encoding the centrosomal protein centrobin. Centrobin acts downstream of PLK4 and CDK2 and complexes with STIL, SAS-6, and tubulin to orchestrate centriole duplication and mitotic spindle assembly. Loss of centrobin function impairs centrosome integrity and mitotic fidelity, linked to genomic instability in Burkitt lymphoma. This knockout model is suited for investigating centrosome biology, cell cycle regulation, and oncogenic mechanisms in B-cell malignancies. Applications include immunofluorescence centrosome staining, flow cytometry cell cycle profiling, mitotic index determination, spindle morphology analysis, and karyotyping to assess chromosomal aberrations.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    CNTROB

    Gene Identifier

    NCBI Gene ID 116840

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% COâ‚‚

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The CNTROB Knockout Raji Polyclonal Cells represent a polyclonal population of Raji B lymphocytes engineered via CRISPR/Cas9-mediated disruption of the CNTROB gene. This product delivers a heterogeneous knockout model, preserving the diverse genetic background typical of polyclonal editing outcomes, without clonal selection. The targeted disruption of CNTROB abolishes expression of the centrobin protein, providing a powerful tool for investigating centrosome biology and mitotic regulation in a human B-cell context.

Raji cells, a well-characterized human Burkitt lymphoma-derived B lymphocyte line, exhibit robust proliferative capacity and express surface immunoglobulins, reflecting their antibody-producing and immune surveillance heritage. These cells are widely employed in immunological and cancer research due to their stable growth characteristics and ease of genetic manipulation. Their B-cell lineage makes them particularly suitable for studying centrosome-associated defects in lymphoid malignancies and for evaluating the contribution of mitotic fidelity to lymphomagenesis.

Centrobin, encoded by CNTROB, is a centrosomal protein indispensable for centriole duplication and mitotic spindle assembly. It functions downstream of critical regulators such as PLK4 and CDK2, and cooperates with STIL and SAS-6 to drive procentriole formation. Centrobin interacts with tubulin and various centriolar satellite proteins, facilitating the organization of spindle poles during mitotic progression. Disruption of CNTROB perturbs the PLK4?CSTIL?CSAS-6?CCPAP?CCEP135?Ccentrobin pathway, leading to failed centriole duplication and compromised bipolar spindle formation, ultimately causing mitotic arrest or aberrant chromosome segregation.

In Raji B lymphocytes, centrosomal integrity is vital for accurate mitosis and maintenance of genomic stability. Loss of centrobin function in these lymphoma-derived cells creates a model of centrosome dysfunction that mirrors abnormalities observed in Burkitt lymphoma and other cancers with mitotic instability. The knockout disrupts spindle pole organization, which can lead to abnormal mitotic progression and aneuploidy, providing insight into how centrosomal defects drive oncogenic processes in B-cell malignancies. This system enables dissection of the molecular events linking centrosome duplication and cell cycle control in a disease-relevant hematopoietic background.

Researchers can employ the CNTROB Knockout Raji Polyclonal Cells in a variety of assays to dissect centrosome biology and cancer cell physiology. Immunofluorescence analysis of centrosome markers allows visualization of aberrant centriole structures, while flow cytometry-based cell cycle analysis reveals mitotic arrest or delayed progression. Additional applications include mitotic index scoring, spindle morphology assessment via tubulin staining, proliferation kinetics, and karyotype analysis to evaluate chromosomal instability. These polyclonal knockout cells serve as a versatile resource for investigating gene dependencies and therapeutic vulnerabilities in B-cell lymphoma. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)